var data={"title":"Neonatal pneumonia","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Neonatal pneumonia</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/contributors\" class=\"contributor contributor_credentials\">Michael E Speer, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/contributors\" class=\"contributor contributor_credentials\">Joseph A Garcia-Prats, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/contributors\" class=\"contributor contributor_credentials\">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/contributors\" class=\"contributor contributor_credentials\">Carrie Armsby, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 27, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pneumonia is an important cause of neonatal infection and accounts for significant morbidity and mortality, especially in developing countries [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/1,2\" class=\"abstract_t\">1,2</a>].</p><p>The epidemiology, microbiology, clinical manifestations, diagnosis, and treatment of neonatal pneumonia are reviewed here. Neonatal sepsis and specific pathogens are discussed separately. (See <a href=\"topic.htm?path=clinical-features-evaluation-and-diagnosis-of-sepsis-in-term-and-late-preterm-infants\" class=\"medical medical_review\">&quot;Clinical features, evaluation, and diagnosis of sepsis in term and late preterm infants&quot;</a> and <a href=\"topic.htm?path=management-and-outcome-of-sepsis-in-term-and-late-preterm-infants\" class=\"medical medical_review\">&quot;Management and outcome of sepsis in term and late preterm infants&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neonatal pneumonia can have early or late onset. Bacteria are the principal pathogens for both types. (See <a href=\"#H8\" class=\"local\">'Microbiology'</a> below.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Routes of acquisition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The route of acquisition varies in part with the time of onset of the pneumonia.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h3\">Early-onset pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Early-onset pneumonia, generally within three days of birth, is acquired from the mother by one of three routes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intrauterine aspiration of infected amniotic fluid.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Transplacental transmission of organisms from the mother to the fetus through the placental circulation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aspiration during or after birth of infected amniotic fluid. The neonate can aspirate vaginal organisms, leading to respiratory colonization and, in some cases, pneumonia. Vaginal colonization with such organisms as group B streptococcus (GBS) does not necessarily result in overt maternal infection.</p><p/><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Late-onset pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Late-onset pneumonia, which occurs during hospitalization or after discharge, generally arises from organisms colonizing the hospitalized newborn or is nosocomially acquired from infected individuals or contaminated equipment. Microorganisms can invade through injured tracheal or bronchial mucosa or through the bloodstream.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Mechanism of injury in GBS pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In GBS pneumonia, the level of beta-hemolysin expression appears to correlate directly with the ability of the organism to injure lung epithelial cells [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/3,4\" class=\"abstract_t\">3,4</a>]. Studies suggest the hemolysin acts as a pore-forming cytolysin. The injury results in increased permeability that contributes to the development of alveolar edema and hemorrhage. This mechanism also may be partially responsible for bloodstream extension. Because surfactant phospholipid inhibits beta-hemolysin-associated lung epithelial cell injury, preterm infants who are deficient in surfactant may be more severely affected [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/3,4\" class=\"abstract_t\">3,4</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">PATHOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathologic changes vary with the type of organism: bacterial or viral. Bacterial pneumonia is characterized by inflammation of the pleura, infiltration or destruction of bronchopulmonary tissue, and leukocyte and fibrinous exudate within alveoli and the <span class=\"nowrap\">bronchi/bronchioles</span> [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/5,6\" class=\"abstract_t\">5,6</a>]. Bacteria often are seen within the interstitial spaces, alveoli, and <span class=\"nowrap\">bronchi/bronchioles</span> [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/5\" class=\"abstract_t\">5</a>].</p><p>Viruses typically cause an interstitial pneumonia. The pneumonia induced by rubella, for example, is characterized by infiltration of mononuclear cells and lymphocytes. Extensive inflammation occasionally occurs with hyaline membrane formation, followed by varying degrees of interstitial fibrosis and scarring [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/7-9\" class=\"abstract_t\">7-9</a>].</p><p class=\"headingAnchor\" id=\"H4043311907\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In resource-rich settings, the estimated incidence of pneumonia is &lt;1 percent among full-term infants and approximately 10 percent in preterm infants [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/10,11\" class=\"abstract_t\">10,11</a>]. By contrast, the incidence of neonatal pneumonia at autopsy ranges from 20 to 32 percent of liveborn and from 15 to 38 percent of stillborn infants [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/11\" class=\"abstract_t\">11</a>].</p><p>Congenital pneumonia is a common cause of mortality among extremely low birth weight (ELBW) infants (ie, BW &lt;1000 g), accounting for nearly 30 percent of deaths in one series [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/12\" class=\"abstract_t\">12</a>]. Pneumonia caused by maternal enteric organisms frequently accompanies chorioamnionitis <span class=\"nowrap\">and/or</span> funisitis in these congenital infections.</p><p>In resource-limited settings, pneumonia is major contributor to infant mortality. The World Health Organization estimated that in 2015 pneumonia caused &gt;900,000 deaths worldwide in children under five years old, with the majority of deaths occurring in infants &lt;1 year old [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/13\" class=\"abstract_t\">13</a>]. In one study conducted in a rural area in central India, mortality secondary to pneumonia in the first month was 29 per 1000 live births; more than one-half of all pneumonia deaths in children occurred in newborns [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/14\" class=\"abstract_t\">14</a>]. These figures may underestimate the burden of neonatal pneumonia in resource-limited settings because many newborns do not receive medical care.</p><p class=\"headingAnchor\" id=\"H3528112393\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Risk factors associated with early-onset pneumonia include prolonged rupture of the fetal membranes (&gt;18 hours), maternal amnionitis, preterm delivery, fetal tachycardia, and maternal intrapartum fever [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/15,16\" class=\"abstract_t\">15,16</a>].</p><p>Infants who require assisted ventilation are at highest risk for late-onset pneumonia. Data from adults, which are thought to be applicable to neonates, suggest that the risk of nosocomial pneumonia is approximately four times higher in intubated than in nonintubated patients [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/17\" class=\"abstract_t\">17</a>]. Other risk factors include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Anomalies of the airway (eg, choanal atresia, tracheoesophageal fistula, and cystic adenomatoid malformations)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe underlying disease</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prolonged hospitalization</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neurologic impairment resulting in aspiration of gastrointestinal contents</p><p/><p>Nosocomial infections occasionally are traced to poor handwashing or overcrowding [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/18\" class=\"abstract_t\">18</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bacterial, viral, spirochetal, protozoan, and fungal pathogens can cause pneumonia.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Early-onset pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bacterial pathogens are the most common cause of early- and late-onset pneumonia, although the specific organisms may differ (<a href=\"image.htm?imageKey=PEDS%2F81323\" class=\"graphic graphic_table graphicRef81323 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Bacterial infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most early-onset pneumonia is caused by aerobic bacteria, although anaerobes such as <em>Bacteroides</em> spp. occasionally are recovered. Group B streptococcus (GBS) is the most common cause of early-onset pneumonia in the United States and other resource-rich countries, although gram negative organisms are emerging cause [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/19\" class=\"abstract_t\">19</a>]. (See <a href=\"topic.htm?path=group-b-streptococcus-virulence-factors-and-pathogenic-mechanisms\" class=\"medical medical_review\">&quot;Group B streptococcus: Virulence factors and pathogenic mechanisms&quot;</a> and <a href=\"topic.htm?path=group-b-streptococcal-infection-in-neonates-and-young-infants#H14\" class=\"medical medical_review\">&quot;Group B streptococcal infection in neonates and young infants&quot;, section on 'Pneumonia'</a>.)</p><p>In one study from the United Kingdom of 35 infants with early-onset pneumonia, GBS was responsible for 57 percent of the cases [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/20\" class=\"abstract_t\">20</a>]. Different organisms may predominate in other locations, especially developing countries [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/2,21-23\" class=\"abstract_t\">2,21-23</a>]. In a review of neonatal pneumonia in developing countries, pathogens responsible for early-onset neonatal sepsis and pneumonia included <em>Escherichia coli</em>, GBS, <em>Klebsiella </em>spp, <em>Staphylococcus aureus</em>, and <em>Streptococcus pneumoniae</em> [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/2\" class=\"abstract_t\">2</a>].</p><p>Other less common bacterial pathogens include <em>Listeria</em> monocytogenes and <em>Mycobacterium tuberculosis</em>, both of which can be transmitted transplacentally. Although transplacental infection by <em>M. tuberculosis</em> often results in primary liver involvement, pneumonia may be the sole manifestation or may accompany hepatic disease [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/24\" class=\"abstract_t\">24</a>]. Tuberculosis (TB) occurs with greater frequency in human immunodeficiency virus (HIV)-infected patients, and congenital TB also has become more common [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/25\" class=\"abstract_t\">25</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Possible link of Ureaplasma urealyticum to chronic lung disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>One bacterial pathogen, <em>Ureaplasma urealyticum</em>, has been linked potentially to the development of acute and chronic lung disease [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/26-30\" class=\"abstract_t\">26-30</a>]. This connection has been shown in both small series and a meta-analysis [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/27\" class=\"abstract_t\">27</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In one study of 47 infants weighing &lt;1500 g, radiographic features of pneumonia were more frequent within seven days in those colonized with <em>U. urealyticum</em> than in noncolonized infants (53 versus 21 percent) [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/26\" class=\"abstract_t\">26</a>]. Evidence of &quot;precocious&quot; chronic lung disease by radiography also was more common in patients with a positive culture for the organism (23 versus 2 percent). Infants with a positive <em>U. urealyticum</em> culture had a relative risk of 11.0 (95% CI 1.6-75.5) for oxygen dependence at 36 postmenstrual weeks [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/26\" class=\"abstract_t\">26</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In another report, tracheal aspirates were obtained prior to administration of surfactant or antibiotics from 105 very low birth weight (VLBW) infants who required mechanical ventilation before 12 hours of age [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/28\" class=\"abstract_t\">28</a>]. Infants positive for <em>U. urealyticum</em> were more likely to have chronic lung disease at 28 days, but not at 36 postmenstrual weeks [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/28\" class=\"abstract_t\">28</a>].</p><p/><p>The efficacy of antimicrobial therapy is uncertain. Two small trials of <a href=\"topic.htm?path=erythromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">erythromycin</a> therapy in colonized infants failed to show an effect on the development of chronic lung disease [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/29,30\" class=\"abstract_t\">29,30</a>]. In addition, there are data to suggest that some isolates of <em>Ureaplasma</em> are not susceptible to erythromycin [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/31-33\" class=\"abstract_t\">31-33</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Viral infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Herpes simplex virus (HSV) is the most common viral agent to cause early-onset pneumonia, usually following acquisition from the mother at the time of birth [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/34\" class=\"abstract_t\">34</a>]. HSV pneumonia occurs in 33 to 54 percent of disseminated HSV infections and usually is fatal in spite of treatment [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/16,34\" class=\"abstract_t\">16,34</a>]. (See <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis#H9\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Clinical features and diagnosis&quot;, section on 'Disseminated disease'</a>.)</p><p>Other viruses can cause pneumonia, usually via transplacental transmission from a mother who acquires the infection late in pregnancy. Examples include adenovirus, enteroviruses, and mumps [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/16,35,36\" class=\"abstract_t\">16,35,36</a>]. Interstitial pneumonitis can also occur in congenital rubella infection and congenital cytomegalovirus (CMV) infection [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/37\" class=\"abstract_t\">37</a>]. (See <a href=\"topic.htm?path=congenital-cytomegalovirus-infection-clinical-features-and-diagnosis#H582408938\" class=\"medical medical_review\">&quot;Congenital cytomegalovirus infection: Clinical features and diagnosis&quot;, section on 'Symptomatic neonate'</a> and <a href=\"topic.htm?path=congenital-rubella-syndrome-clinical-features-and-diagnosis#H10\" class=\"medical medical_review\">&quot;Congenital rubella syndrome: Clinical features and diagnosis&quot;, section on 'In neonates'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Fungal infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Candida </em>spp. and other fungal pathogens also are responsible for neonatal pneumonia [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/38,39\" class=\"abstract_t\">38,39</a>]. In one prospective study, approximately 25 percent of VLBW infants were colonized by <em>Candida</em> in the gastrointestinal and respiratory tracts, presumably during labor and delivery [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/40\" class=\"abstract_t\">40</a>]. Pneumonia occurs in approximately 70 percent of infants with systemic candidiasis [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/41\" class=\"abstract_t\">41</a>].</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Other pathogens</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Occasionally, early-onset pneumonia is seen in patients with congenital toxoplasmosis and syphilis [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/42\" class=\"abstract_t\">42</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Late-onset pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hospitalized infants often are colonized with organisms that are different from normal flora and these can cause late-onset pneumonia.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Bacterial infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is limited information on the bacterial etiology for community-acquired, late-onset pneumonia [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/2\" class=\"abstract_t\">2</a>]. There appears to be a predominance of gram-positive bacteria including <em>S. pyogenes</em>, <em>S. aureus</em>, and <em>S. pneumoniae</em>. Other bacterial pathogens have been implicated in late-onset pneumonia, some of which have characteristic features:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. aureus</em> and <em>Klebsiella pneumoniae</em> are notable for inducing extensive tissue damage, abscess formation, and empyema [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/43\" class=\"abstract_t\">43</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>These and other pathogens (eg, <em>Escherichia coli</em>, <em>Serratia marcescens</em>, <em>Enterobacter cloacae</em>, <em>S. pneumoniae</em>, and <em>Pseudomonas aeruginosa</em>) may cause pneumatoceles [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/44-46\" class=\"abstract_t\">44-46</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Citrobacter diversus</em>, frequently associated with brain abscesses in neonates, can also cause lung abscess [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/44\" class=\"abstract_t\">44</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Bacillus cereus</em> has been associated with necrotizing pneumonia in preterm infants [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/47\" class=\"abstract_t\">47</a>] and with pneumonia secondary to contaminated ventilator circuits [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/48\" class=\"abstract_t\">48</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Chlamydia trachomatis</em> has a long incubation period and typically is associated with pneumonia occurring between two and four weeks of age [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/49\" class=\"abstract_t\">49</a>]. A possible association between early lung disease and a positive tracheal culture for <em>C. trachomatis</em> has been reported [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/50\" class=\"abstract_t\">50</a>]. In developing countries where untreated sexually transmitted disease is common, <em>C. trachomatis</em> nasal carriage rate is between 15 and 20 percent and is a risk factor for pneumonia [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/2,22,51\" class=\"abstract_t\">2,22,51</a>].</p><p/><p class=\"headingAnchor\" id=\"H17\"><span class=\"h3\">Viral infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Numerous viruses, including adenovirus, parainfluenza, rhinovirus, enteroviruses, influenza, and respiratory syncytial virus (RSV), cause pneumonia in the neonatal period [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/16,52,53\" class=\"abstract_t\">16,52,53</a>]. Most infants initially are healthy, but have ill family members. In a series of 40 newborns with viral pneumonia, nine were born at less than 37 weeks gestation, and RSV accounted for 55 percent of the cases [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/52\" class=\"abstract_t\">52</a>]. RSV is most prevalent during the winter months and results in significant morbidity and mortality. Viral pathogens are also a common cause of hospital-acquired respiratory infections in the neonatal intensive care unit. (See <a href=\"topic.htm?path=nosocomial-viral-infections-in-the-neonatal-intensive-care-unit#H5\" class=\"medical medical_review\">&quot;Nosocomial viral infections in the neonatal intensive care unit&quot;, section on 'Respiratory viruses'</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h3\">Fungal infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Candida</em> spp. occasionally cause late-onset pneumonia, particularly in extremely low birth weight (ELBW) infants who have received prolonged antibiotic therapy and have respiratory tract colonization [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/21,54-56\" class=\"abstract_t\">21,54-56</a>]. Corticosteroid administration may increase the risk of systemic infection from <em>Candida</em> spp. in preterm infants [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/57,58\" class=\"abstract_t\">57,58</a>], potentially increasing the risk of pneumonia.</p><p>A rare cause of pneumonia is <em>aspergillosis</em>, which frequently is fatal [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/59\" class=\"abstract_t\">59</a>]. Aspergillus infection can occur in clusters, particularly during hospital renovations [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/60\" class=\"abstract_t\">60</a>].</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Early-onset pneumonia commonly presents with respiratory distress beginning at or soon after birth. Infants may have associated lethargy, apnea, tachycardia, and poor perfusion, sometimes progressing to septic shock. Some infants develop pulmonary hypertension. Other signs include temperature instability, metabolic acidosis, and abdominal distension. None of these signs is specific for pneumonia, and respiratory distress also can be caused by noninfectious causes (<a href=\"image.htm?imageKey=PEDS%2F56457\" class=\"graphic graphic_table graphicRef56457 \">table 2</a>).</p><p>Late-onset pneumonia is marked by changes in the overall condition of the newborn and can include nonspecific signs of apnea, tachypnea, poor feeding, abdominal distention, jaundice, emesis, respiratory distress, and circulatory collapse. Ventilator-dependent infants may have increased oxygen and ventilator requirements or purulent tracheal secretions.</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of neonatal pneumonia is based on a combination of clinical, radiographic, and microbiologic findings. Because signs of pneumonia are nonspecific, neonates with sudden onset of respiratory distress or other signs of illness should be evaluated for pneumonia, including a complete sepsis evaluations. The evaluation for neonatal sepsis is discussed in greater detail separately. (See <a href=\"topic.htm?path=clinical-features-evaluation-and-diagnosis-of-sepsis-in-term-and-late-preterm-infants#H12\" class=\"medical medical_review\">&quot;Clinical features, evaluation, and diagnosis of sepsis in term and late preterm infants&quot;, section on 'Evaluation and initial management'</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Cultures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cultures of blood and cerebrospinal fluid should be obtained. In infants who are intubated, Gram stain and culture of tracheal aspirates may help identify the pathogen [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/61-64\" class=\"abstract_t\">61-64</a>]. In patients with pleural effusions, if pleural fluid is sampled for therapeutic reasons, it can be sent for Gram stain and culture. If viral or other nonbacterial infection is suspected, specific studies should be obtained including polymerase chain reaction (PCR) and viral cultures. </p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Chest radiography</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The chest radiograph can confirm the clinical diagnosis of pneumonia. Bilateral alveolar densities with air bronchograms are characteristic [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/65\" class=\"abstract_t\">65</a>], but irregular patchy infiltrates or occasionally a normal pattern also occur [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/66\" class=\"abstract_t\">66</a>]. Pneumonia caused by group B streptococcus (GBS) or other pathogens is difficult to distinguish from respiratory distress syndrome (RDS) in preterm infants [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/67-69\" class=\"abstract_t\">67-69</a>]. The presence of pleural effusions may be helpful because they occur in up to 67 percent of patients with pneumonia, but are rarely found in RDS. However, pleural effusions also can be seen in patients with transient tachypnea of the newborn, congenital heart disease, hydrops fetalis, and congenital lymphangiectasia [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/66\" class=\"abstract_t\">66</a>].</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Successful treatment depends upon the pathogen, early recognition of the infection, and early therapy prior to the development of irreversible injury.</p><p>Depending on the severity of respiratory distress, initial management may include oxygen supplementation and mechanical ventilation, in addition to empirical antibiotic therapy. (See <a href=\"topic.htm?path=overview-of-neonatal-respiratory-distress-disorders-of-transition#H16\" class=\"medical medical_review\">&quot;Overview of neonatal respiratory distress: Disorders of transition&quot;, section on 'Initial management'</a>.)</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h2\">Bacterial infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The choice of empiric regimens is based upon whether the infection is early or late onset.</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h3\">Early-onset pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For early-onset pneumonia (ie, age &le;3 days), empiric parenteral antibiotic treatment is started until culture results are available. Once a specific organism is identified, therapy is modified according to the susceptibility pattern.</p><p>For most neonates, we suggest initial empiric coverage with <a href=\"topic.htm?path=ampicillin-pediatric-drug-information\" class=\"drug drug_pediatric\">ampicillin</a> and <a href=\"topic.htm?path=gentamicin-pediatric-drug-information\" class=\"drug drug_pediatric\">gentamicin</a> (dosing is based upon weight, renal function, postnatal age, and postmenstrual age) [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/70\" class=\"abstract_t\">70</a>]. Ampicillin is effective against group B streptococcus (GBS), most other strains of streptococci, <em>L. monocytogenes</em>, and some gram-negative bacteria. Ampicillin plus gentamicin also has synergistic activity against many of these organisms [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/71\" class=\"abstract_t\">71</a>]. In communities in which a substantial proportion of gram-negative bacilli are resistant to gentamicin, another aminoglycoside (eg, <a href=\"topic.htm?path=amikacin-pediatric-drug-information\" class=\"drug drug_pediatric\">amikacin</a>) should be substituted.</p><p>Third-generation cephalosporins, although active against many gram-negative organisms, should not generally be used for suspected early-onset sepsis or pneumonia. Gram-negative bacilli can rapidly develop resistance to cephalosporins by either inducible or chromosomally mediated beta-lactamase activity [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/71,72\" class=\"abstract_t\">71,72</a>]. In addition, a large observational study found that the risk of death from early-onset sepsis was increased in neonates who received <a href=\"topic.htm?path=cefotaxime-pediatric-drug-information\" class=\"drug drug_pediatric\">cefotaxime</a> as initial empiric treatment compared with those who received <a href=\"topic.htm?path=gentamicin-pediatric-drug-information\" class=\"drug drug_pediatric\">gentamicin</a> [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/73\" class=\"abstract_t\">73</a>].</p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h3\">Late-onset pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The choice of empiric therapy for late-onset pneumonia depends upon the prevalence and sensitivity of bacteria in both the community and the hospital. For most term infants &gt;3 days old, we suggest <a href=\"topic.htm?path=vancomycin-pediatric-drug-information\" class=\"drug drug_pediatric\">vancomycin</a> plus an aminoglycoside for initial therapy because of the high prevalence of staphylococcal species resistant to penicillins (eg, <em>Staphylococcus epidermidis</em> and methicillin-resistant <em>S. aureus</em> [MRSA]). Dosing of these medications is based upon the infant's weight, renal function, postnatal age, and postmenstrual age. Because of the emergence of vancomycin-resistant enterococci (VRE) and <em>S. aureus</em> with reduced susceptibility to vancomycin, vancomycin should be continued only if there is no alternative [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/74\" class=\"abstract_t\">74</a>].</p><p>Isolation of extended spectrum beta-lactamase (ESBL)-producing organisms is increasing. <a href=\"topic.htm?path=meropenem-pediatric-drug-information\" class=\"drug drug_pediatric\">Meropenem</a> is the drug of choice for treatment of infections caused by these organisms [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/70,71,75\" class=\"abstract_t\">70,71,75</a>]. Meropenem is active against gram-negative aerobic organisms with chromosomally mediated ampC beta-lactamases or ESBL-producing strains, except carbapenemase-producing strains. <a href=\"http://redbook.solutions.aap.org/drug.aspx?gbosId=171094&amp;token=E5X73DZxX2bOleuZ3358XOBllUIfrhg2lRqJcKgjo50fHlk16od7DdPfKN/7xeZzMyqYLX3JVK05OXL4mLJ5B68AtSQsFLDSFqHlsS1NKKs=&amp;TOPIC_ID=5004\" target=\"_blank\" class=\"external\">Amikacin</a> has the most activity against ESBL-producing strains among the aminoglycosides.</p><p>The duration of therapy is guided by the infecting pathogen and the response of the patient. The usual treatment course for uncomplicated pneumonia is 10 to 14 days.</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h2\">Viral infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Specific agents for the treatment of viral pneumonia are limited. For most viral infections acquired in the perinatal or postnatal period, therapy remains supportive.</p><p class=\"headingAnchor\" id=\"H29\"><span class=\"h3\">Herpes simplex virus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If herpes simplex virus (HSV) pneumonia is suspected, intravenous <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> (60 <span class=\"nowrap\">mg/kg</span> per day in 3 divided doses for 21 days) is recommended [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/76\" class=\"abstract_t\">76</a>]. HSV pneumonia usually is fatal despite treatment [<a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/16,34\" class=\"abstract_t\">16,34</a>]. (See <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis#H9\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Clinical features and diagnosis&quot;, section on 'Disseminated disease'</a> and <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention#H4\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Management and prevention&quot;, section on 'Acyclovir therapy'</a>.)</p><p class=\"headingAnchor\" id=\"H30\"><span class=\"h3\">Respiratory syncytial virus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=ribavirin-pediatric-drug-information\" class=\"drug drug_pediatric\">Ribavirin</a> is the only available specific treatment for respiratory syncytial virus (RSV) pneumonia; however, it is generally not recommended in infants and young children because efficacy in this population has not clearly been proven. RSV prophylaxis is suggested for high-risk infants (eg, those with chronic lung disease <span class=\"nowrap\">and/or</span> born at &lt;29 weeks gestation). (See <a href=\"topic.htm?path=respiratory-syncytial-virus-infection-treatment#H9\" class=\"medical medical_review\">&quot;Respiratory syncytial virus infection: Treatment&quot;, section on 'Ribavirin'</a> and <a href=\"topic.htm?path=respiratory-syncytial-virus-infection-prevention#H104278870\" class=\"medical medical_review\">&quot;Respiratory syncytial virus infection: Prevention&quot;, section on 'Indications for palivizumab'</a>.)</p><p class=\"headingAnchor\" id=\"H31\"><span class=\"h1\">OUTCOME</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The prognosis of neonatal pneumonia depends upon the severity of the disease, the gestational age of the patient, underlying medical conditions, and the infecting organism. Increased mortality is associated with preterm birth, preexisting chronic lung disease, or immune deficiencies. Most term neonates managed in resource-rich settings recover well without long-term sequelae.</p><p class=\"headingAnchor\" id=\"H2114404157\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-sepsis-in-neonates\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Sepsis in neonates&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-pediatric-pneumonia\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Pediatric pneumonia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2128161\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pneumonia is an important cause of neonatal infection and is a major contributor to infant mortality worldwide. In resource-rich countries, the estimated incidence of pneumonia in full-term infants is &lt;1 percent and increases to 10 percent in preterm infants. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above and <a href=\"#H4043311907\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neonatal pneumonia can be classified by the infant's age as follows:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Early-onset pneumonia (&le;3 days), which is generally acquired from the mother during labor or delivery. (See <a href=\"#H4\" class=\"local\">'Early-onset pneumonia'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Late-onset pneumonia (&gt;3 days of age) is typically due to nosocomial organisms from previous colonization of the infant or transmission from care providers or contaminated equipment. (See <a href=\"#H5\" class=\"local\">'Late-onset pneumonia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There are a large number of viral, bacterial, and fungal pathogens that cause neonatal pneumonia (<a href=\"image.htm?imageKey=PEDS%2F81323\" class=\"graphic graphic_table graphicRef81323 \">table 1</a>). Early-onset bacterial pneumonia is most commonly caused by group B streptococcus. (See <a href=\"#H8\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Risk factors associated with early-onset pneumonia include prolonged rupture of the fetal membranes (&gt;18 hours), maternal amnionitis, preterm delivery, fetal tachycardia, and maternal intrapartum fever. Late-onset disease is associated with mechanical ventilation, airway anomalies, prolonged hospitalization, and aspiration of gastrointestinal contents due to neurologic impairment. (See <a href=\"#H3528112393\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Early-onset pneumonia commonly presents with respiratory distress beginning at or soon after birth. Other clinical manifestations, also seen in late-onset disease, are nonspecific and include temperature instability, apnea, lethargy, tachycardia, poor perfusion, tachypnea, and poor feeding. (See <a href=\"#H20\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of neonatal pneumonia is based on a combination of clinical, radiographic, and microbiologic findings. (See <a href=\"#H21\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infants with pneumonia should be treated with empirical antibiotic therapy that provides broad coverage for the most likely pathogens. The choice of antibiotic regimen depends on timing of disease onset (early- versus late-onset) and local antibiotic resistance patterns. For most full-term neonates with early-onset pneumonia, we suggest initial empiric coverage with <a href=\"topic.htm?path=ampicillin-pediatric-drug-information\" class=\"drug drug_pediatric\">ampicillin</a> and <a href=\"topic.htm?path=gentamicin-pediatric-drug-information\" class=\"drug drug_pediatric\">gentamicin</a> (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). For most full-term neonates with late-onset pneumonia, we suggest initial empiric coverage with <a href=\"topic.htm?path=vancomycin-pediatric-drug-information\" class=\"drug drug_pediatric\">vancomycin</a> plus an aminoglycoside (eg, gentamicin) (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). When results of microbiologic tests are available, antibiotic therapy is directed toward the specific pathogen. (See <a href=\"#H24\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The prognosis of neonatal pneumonia depends upon the severity of the disease, the gestational age of the patient, underlying medical conditions, and the infecting organism. (See <a href=\"#H31\" class=\"local\">'Outcome'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/1\" class=\"nounderline abstract_t\">Stoll BJ. The global impact of neonatal infection. Clin Perinatol 1997; 24:1.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/2\" class=\"nounderline abstract_t\">Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed 2005; 90:F211.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/3\" class=\"nounderline abstract_t\">Nizet V, Gibson RL, Rubens CE. The role of group B streptococci beta-hemolysin expression in newborn lung injury. Adv Exp Med Biol 1997; 418:627.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/4\" class=\"nounderline abstract_t\">Gibson RL, Nizet V, Rubens CE. Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res 1999; 45:626.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/5\" class=\"nounderline abstract_t\">DAVIES PA, AHERNE W. Congenital pneumonia. Arch Dis Child 1962; 37:598.</a></li><li class=\"breakAll\">Robbins SL. The Respiratory System &ndash; Lung. In: Textbook of Pathology With Clinical Application, WB Saunders, Philadelphia 1962. p.562.</li><li class=\"breakAll\">Hanshaw JB, Dudgeon JA. Rubella. In: Viral Diseases of the Fetus and Newborn, WB Saunders, Philadelphia 1978. p.17.</li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/8\" class=\"nounderline abstract_t\">Singer DB, Rudolph AJ, Rosenberg HS, et al. Pathology of the congenital rubella syndrome. J Pediatr 1967; 71:665.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/9\" class=\"nounderline abstract_t\">Korones SB, Ainger LE, Monif GR, et al. Congenital rubella syndrome: New clinical aspects with recovery of virus from affected infants. J Pediatr 1965; 67:166.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/10\" class=\"nounderline abstract_t\">Sinha A, Yokoe D, Platt R. Epidemiology of neonatal infections: experience during and after hospitalization. Pediatr Infect Dis J 2003; 22:244.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/11\" class=\"nounderline abstract_t\">Nissen MD. Congenital and neonatal pneumonia. Paediatr Respir Rev 2007; 8:195.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/12\" class=\"nounderline abstract_t\">Barton L, Hodgman JE, Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999; 103:446.</a></li><li class=\"breakAll\">World Health Organization, Pneumonia fact sheet. Available at: http://www.who.int/mediacentre/factsheets/fs331/en/.</li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/14\" class=\"nounderline abstract_t\">Bang AT, Bang RA, Morankar VP, et al. Pneumonia in neonates: can it be managed in the community? Arch Dis Child 1993; 68:550.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/15\" class=\"nounderline abstract_t\">Spaans WA, Knox AJ, Koya HB, Mantell CD. Risk factors for neonatal infection. Aust N Z J Obstet Gynaecol 1990; 30:327.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/16\" class=\"nounderline abstract_t\">Campbell JR. Neonatal pneumonia. Semin Respir Infect 1996; 11:155.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/17\" class=\"nounderline abstract_t\">Cross AS, Roup B. Role of respiratory assistance devices in endemic nosocomial pneumonia. Am J Med 1981; 70:681.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/18\" class=\"nounderline abstract_t\">Harbarth S, Sudre P, Dharan S, et al. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 1999; 20:598.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/19\" class=\"nounderline abstract_t\">Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect 2014; 68 Suppl 1:S24.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/20\" class=\"nounderline abstract_t\">Webber S, Wilkinson AR, Lindsell D, et al. Neonatal pneumonia. Arch Dis Child 1990; 65:207.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/21\" class=\"nounderline abstract_t\">Dennehy PH. Respiratory infections in the newborn. Clin Perinatol 1987; 14:667.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/22\" class=\"nounderline abstract_t\">Muhe L, Tilahun M, Lulseged S, et al. Etiology of pneumonia, sepsis and meningitis in infants younger than three months of age in Ethiopia. Pediatr Infect Dis J 1999; 18:S56.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/23\" class=\"nounderline abstract_t\">Prasertsom W, Horpaopan S, Ratrisawadi V, et al. Early versus late onset neonatal septicemia at Children's Hospital. J Med Assoc Thai 1990; 73:106.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/24\" class=\"nounderline abstract_t\">Starke JR. Tuberculosis. An old disease but a new threat to the mother, fetus, and neonate. Clin Perinatol 1997; 24:107.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/25\" class=\"nounderline abstract_t\">Adhikari M, Pillay T, Pillay DG. Tuberculosis in the newborn: an emerging disease. Pediatr Infect Dis J 1997; 16:1108.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/26\" class=\"nounderline abstract_t\">Pacifico L, Panero A, Roggini M, et al. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. Pediatr Infect Dis J 1997; 16:579.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/27\" class=\"nounderline abstract_t\">Wang EE, Ohlsson A, Kellner JD. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis. J Pediatr 1995; 127:640.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/28\" class=\"nounderline abstract_t\">Perzigian RW, Adams JT, Weiner GM, et al. Ureaplasma urealyticum and chronic lung disease in very low birth weight infants during the exogenous surfactant era. Pediatr Infect Dis J 1998; 17:620.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/29\" class=\"nounderline abstract_t\">Lyon AJ, McColm J, Middlemist L, et al. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998; 78:F10.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/30\" class=\"nounderline abstract_t\">Bowman ED, Dharmalingam A, Fan WQ, et al. Impact of erythromycin on respiratory colonization of Ureaplasma urealyticum and the development of chronic lung disease in extremely low birth weight infants. Pediatr Infect Dis J 1998; 17:615.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/31\" class=\"nounderline abstract_t\">Waites KB, Crouse DT, Cassell GH. Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates. Pediatr Infect Dis J 1992; 11:23.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/32\" class=\"nounderline abstract_t\">Walls SA, Kong L, Leeming HA, et al. Antibiotic prophylaxis improves Ureaplasma-associated lung disease in suckling mice. Pediatr Res 2009; 66:197.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/33\" class=\"nounderline abstract_t\">Weisman LE, Leeming AH, Kong L. Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse. Pediatr Res 2012; 72:502.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/34\" class=\"nounderline abstract_t\">Barker JA, McLean SD, Jordan GD, et al. Primary neonatal herpes simplex virus pneumonia. Pediatr Infect Dis J 1990; 9:285.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/35\" class=\"nounderline abstract_t\">Meyer K, Girgis N, McGravey V. Adenovirus associated with congenital pleural effusion. J Pediatr 1985; 107:433.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/36\" class=\"nounderline abstract_t\">Groenendaal F, Rothbarth PH, van den Anker JN, Spritzer R. Congenital mumps pneumonia: a rare cause of neonatal respiratory distress. Acta Paediatr Scand 1990; 79:1252.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/37\" class=\"nounderline abstract_t\">Liu LW, Qian JH, Zhu TW, et al. [A 5-year retrospective clinical study of perinatal cytomegalovirus infection]. Zhongguo Dang Dai Er Ke Za Zhi 2016; 18:99.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/38\" class=\"nounderline abstract_t\">Ng PC, Siu YK, Lewindon PJ, et al. Congenital Candida pneumonia in a preterm infant. J Paediatr Child Health 1994; 30:552.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/39\" class=\"nounderline abstract_t\">Gerberding KM, Eisenhut CC, Engle WA, Cohen MD. Congenital candida pneumonia and sepsis: a case report and review of the literature. J Perinatol 1989; 9:159.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/40\" class=\"nounderline abstract_t\">Baley JE, Kliegman RM, Boxerbaum B, Fanaroff AA. Fungal colonization in the very low birth weight infant. Pediatrics 1986; 78:225.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/41\" class=\"nounderline abstract_t\">Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics 1984; 73:144.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/42\" class=\"nounderline abstract_t\">Edell DS, Davidson JJ, Mulvihill DM, Majure M. A common presentation of an uncommon cause of neonatal respiratory distress: pneumonia alba. Pediatr Pulmonol 1993; 15:376.</a></li><li class=\"breakAll\">Marks MI, Klein JO. Infectious Diseases of the Fetus &amp; Newborn, Remington JS, Klein JO (Eds), W B Saunders Company, Philadelphia 1995. p.899.</li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/44\" class=\"nounderline abstract_t\">Shamir R, Horev G, Merlob P, Nutman J. Citrobacter diversus lung abscess in a preterm infant. Pediatr Infect Dis J 1990; 9:221.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/45\" class=\"nounderline abstract_t\">Khan EA, Wafelman LS, Garcia-Prats JA, Taber LH. Serratia marcescens pneumonia, empyema and pneumatocele in a preterm neonate. Pediatr Infect Dis J 1997; 16:1003.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/46\" class=\"nounderline abstract_t\">Glustein JZ, Kaplan M. Enterobacter cloacae causing pneumatocele in a neonate. Acta Paediatr 1994; 83:990.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/47\" class=\"nounderline abstract_t\">Jevon GP, Dunne WM Jr, Hicks MJ, Langston C. Bacillus cereus pneumonia in premature neonates: a report of two cases. Pediatr Infect Dis J 1993; 12:251.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/48\" class=\"nounderline abstract_t\">Gray J, George RH, Durbin GM, et al. An outbreak of Bacillus cereus respiratory tract infections on a neonatal unit due to contaminated ventilator circuits. J Hosp Infect 1999; 41:19.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/49\" class=\"nounderline abstract_t\">Jain S. Perinatally acquired Chlamydia trachomatis associated morbidity in young infants. J Matern Fetal Med 1999; 8:130.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/50\" class=\"nounderline abstract_t\">Colarizi P, Chiesa C, Pacifico L, et al. Chlamydia trachomatis-associated respiratory disease in the very early neonatal period. Acta Paediatr 1996; 85:991.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/51\" class=\"nounderline abstract_t\">Lehmann D, Sanders RC, Marjen B, et al. High rates of Chlamydia trachomatis infections in young Papua New Guinean infants. Pediatr Infect Dis J 1999; 18:S62.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/52\" class=\"nounderline abstract_t\">Abzug MJ, Beam AC, Gyorkos EA, Levin MJ. Viral pneumonia in the first month of life. Pediatr Infect Dis J 1990; 9:881.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/53\" class=\"nounderline abstract_t\">Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 1998; 102:531.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/54\" class=\"nounderline abstract_t\">Rowen JL, Rench MA, Kozinetz CA, et al. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr 1994; 124:789.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/55\" class=\"nounderline abstract_t\">Loke HL, Verber I, Szymonowicz W, Yu VY. Systemic candidiasis and pneumonia in preterm infants. Aust Paediatr J 1988; 24:138.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/56\" class=\"nounderline abstract_t\">Narang A, Agrawal PB, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Trop Pediatr 1998; 44:104.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/57\" class=\"nounderline abstract_t\">Groll AH, Jaeger G, Allendorf A, et al. Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life. Clin Infect Dis 1998; 27:437.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/58\" class=\"nounderline abstract_t\">Botas CM, Kurlat I, Young SM, Sola A. Disseminated candidal infections and intravenous hydrocortisone in preterm infants. Pediatrics 1995; 95:883.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/59\" class=\"nounderline abstract_t\">Rowen JL, Atkins JT, Levy ML, et al. Invasive fungal dermatitis in the &lt; or = 1000-gram neonate. Pediatrics 1995; 95:682.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/60\" class=\"nounderline abstract_t\">Krasinski K, Holzman RS, Hanna B, et al. Nosocomial fungal infection during hospital renovation. Infect Control 1985; 6:278.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/61\" class=\"nounderline abstract_t\">Sherman MP, Goetzman BW, Ahlfors CE, Wennberg RP. Tracheal asiration and its clinical correlates in the diagnosis of congenital pneumonia. Pediatrics 1980; 65:258.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/62\" class=\"nounderline abstract_t\">Katayama Y, Minami H, Enomoto M, et al. Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated pneumonia in extremely preterm neonates. J Perinatol 2010; 30:270.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/63\" class=\"nounderline abstract_t\">Booth GR, Al-Hosni M, Ali A, Keenan WJ. The utility of tracheal aspirate cultures in the immediate neonatal period. J Perinatol 2009; 29:493.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/64\" class=\"nounderline abstract_t\">Ruderman JW, Srugo I, Morgan MA, et al. Pneumonia in the neonatal intensive care unit. Diagnosis by quantitative bacterial tracheal aspirate cultures. J Perinatol 1994; 14:182.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/65\" class=\"nounderline abstract_t\">Haney PJ, Bohlman M, Sun CC. Radiographic findings in neonatal pneumonia. AJR Am J Roentgenol 1984; 143:23.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/66\" class=\"nounderline abstract_t\">Cleveland RH. A radiologic update on medical diseases of the newborn chest. Pediatr Radiol 1995; 25:631.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/67\" class=\"nounderline abstract_t\">Hemming VG, McCloskey DW, Hill HR. Pneumonia in the neonate associated with group B streptococcal septicemia. Am J Dis Child 1976; 130:1231.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/68\" class=\"nounderline abstract_t\">Speer M, Rosan RC, Rudolph AJ. Hemophilus influenzae infection in the neonate mimicking respiratory distress syndrome. J Pediatr 1978; 93:295.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/69\" class=\"nounderline abstract_t\">Bortolussi R, Thompson TR, Ferrieri P. Early-onset pneumococcal sepsis in newborn infants. Pediatrics 1977; 60:352.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Tables of antibacterial drug dosages, Table 4.2. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.882.</li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/71\" class=\"nounderline abstract_t\">Edwards MS. Antibacterial therapy in pregnancy and neonates. Clin Perinatol 1997; 24:251.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/72\" class=\"nounderline abstract_t\">Gustaferro CA, Steckelberg JM. Cephalosporin antimicrobial agents and related compounds. Mayo Clin Proc 1991; 66:1064.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/73\" class=\"nounderline abstract_t\">Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 117:67.</a></li><li><a href=\"https://www.uptodate.com/contents/neonatal-pneumonia/abstract/74\" class=\"nounderline abstract_t\">Perl TM. The threat of vancomycin resistance. Am J Med 1999; 106:26S.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Escherichia coli and other Gram-negative bacilli (septicemia and meningitis in neonates). In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.340.</li><li class=\"breakAll\">American Academy of Pediatrics. Herpes simplex. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.432.</li></ol></div><div id=\"topicVersionRevision\">Topic 5004 Version 23.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H2128161\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">PATHOGENESIS</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Routes of acquisition</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">- Early-onset pneumonia</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">- Late-onset pneumonia</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">Mechanism of injury in GBS pneumonia</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">PATHOLOGY</a></li><li><a href=\"#H4043311907\" id=\"outline-link-H4043311907\">EPIDEMIOLOGY</a></li><li><a href=\"#H3528112393\" id=\"outline-link-H3528112393\">RISK FACTORS</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">MICROBIOLOGY</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">Early-onset pneumonia</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">- Bacterial infections</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Possible link of Ureaplasma urealyticum to chronic lung disease</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Viral infections</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">- Fungal infections</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">- Other pathogens</a></li></ul></li><li><a href=\"#H15\" id=\"outline-link-H15\">Late-onset pneumonia</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">- Bacterial infections</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">- Viral infections</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">- Fungal infections</a></li></ul></li></ul></li><li><a href=\"#H20\" id=\"outline-link-H20\">CLINICAL MANIFESTATIONS</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">DIAGNOSIS</a><ul><li><a href=\"#H22\" id=\"outline-link-H22\">Cultures</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">Chest radiography</a></li></ul></li><li><a href=\"#H24\" id=\"outline-link-H24\">TREATMENT</a><ul><li><a href=\"#H25\" id=\"outline-link-H25\">Bacterial infection</a><ul><li><a href=\"#H26\" id=\"outline-link-H26\">- Early-onset pneumonia</a></li><li><a href=\"#H27\" id=\"outline-link-H27\">- Late-onset pneumonia</a></li></ul></li><li><a href=\"#H28\" id=\"outline-link-H28\">Viral infections</a><ul><li><a href=\"#H29\" id=\"outline-link-H29\">- Herpes simplex virus</a></li><li><a href=\"#H30\" id=\"outline-link-H30\">- Respiratory syncytial virus</a></li></ul></li></ul></li><li><a href=\"#H31\" id=\"outline-link-H31\">OUTCOME</a></li><li><a href=\"#H2114404157\" id=\"outline-link-H2114404157\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H2128161\" id=\"outline-link-H2128161\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/5004|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/81323\" class=\"graphic graphic_table\">- Causes of neonatal pneumonia</a></li><li><a href=\"image.htm?imageKey=PEDS/56457\" class=\"graphic graphic_table\">- Noninfectious causes of RD</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-evaluation-and-diagnosis-of-sepsis-in-term-and-late-preterm-infants\" class=\"medical medical_review\">Clinical features, evaluation, and diagnosis of sepsis in term and late preterm infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-cytomegalovirus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Congenital cytomegalovirus infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-rubella-syndrome-clinical-features-and-diagnosis\" class=\"medical medical_review\">Congenital rubella syndrome: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=group-b-streptococcal-infection-in-neonates-and-young-infants\" class=\"medical medical_review\">Group B streptococcal infection in neonates and young infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=group-b-streptococcus-virulence-factors-and-pathogenic-mechanisms\" class=\"medical medical_review\">Group B streptococcus: Virulence factors and pathogenic mechanisms</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-and-outcome-of-sepsis-in-term-and-late-preterm-infants\" class=\"medical medical_review\">Management and outcome of sepsis in term and late preterm infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Management and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nosocomial-viral-infections-in-the-neonatal-intensive-care-unit\" class=\"medical medical_review\">Nosocomial viral infections in the neonatal intensive care unit</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-neonatal-respiratory-distress-disorders-of-transition\" class=\"medical medical_review\">Overview of neonatal respiratory distress: Disorders of transition</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=respiratory-syncytial-virus-infection-prevention\" class=\"medical medical_review\">Respiratory syncytial virus infection: Prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=respiratory-syncytial-virus-infection-treatment\" class=\"medical medical_review\">Respiratory syncytial virus infection: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-pediatric-pneumonia\" class=\"medical medical_society_guidelines\">Society guideline links: Pediatric pneumonia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-sepsis-in-neonates\" class=\"medical medical_society_guidelines\">Society guideline links: Sepsis in neonates</a></li></ul></div></div>","javascript":null}